Liquidia Corporation Common Stock
LQDA Real Time Price USDRecent trades of LQDA by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by LQDA's directors and management
Government lobbying spending instances
-
$60,000 Oct 18, 2024 Issue: Health Issues
-
$60,000 Jul 20, 2024 Issue: Health Issues
-
$60,000 Apr 22, 2024 Issue: Health Issues
-
$60,000 Jan 22, 2024 Issue: Health Issues
-
$20,000 Oct 19, 2023 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Dry powder treprostinil for the treatment of pulmonary hypertension Sep. 05, 2023
-
Patent Title: Dry powder treprostinil for the treatment of pulmonary hypertension Sep. 05, 2023
-
Patent Title: Dry powder treprostinil for the treatment of pulmonary hypertension Aug. 01, 2023
-
Patent Title: Dry powder treprostinil for the treatment of pulmonary hypertension May. 30, 2023
-
Patent Title: Dry powder treprostinil for the treatment of pulmonary hypertension Jan. 26, 2021
-
Patent Title: Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom Jul. 21, 2020
-
Patent Title: Method for producing patterned materials Aug. 29, 2017
-
Patent Title: Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom May. 30, 2017
-
Patent Title: System and method for producing particles and patterned films Jan. 17, 2017
-
Patent Title: Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom May. 17, 2016
-
Patent Title: Nanostructured surfaces for biomedical/biomaterial applications and processes thereof Apr. 19, 2016
-
Patent Title: Method for producing patterned materials Dec. 08, 2015
-
Patent Title: Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom Feb. 03, 2015
-
Patent Title: Nanostructured surfaces for biomedical/biomaterial applications and processes thereof Feb. 03, 2015
-
Patent Title: Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom Mar. 04, 2014
-
Patent Title: System and method for producing particles and patterned films Aug. 27, 2013
-
Patent Title: Method for producing patterned materials May. 21, 2013
-
Patent Title: Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom May. 14, 2013
-
Patent Title: Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom Mar. 06, 2012
-
Patent Title: System and method for producing particles and patterned films Jul. 12, 2011
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of LQDA in WallStreetBets Daily Discussion
Recent insights relating to LQDA
Recent picks made for LQDA stock on CNBC
ETFs with the largest estimated holdings in LQDA
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view LQDA Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.